-
Q&A
Learning Emotional JudoPsychiatrist Andrew Roth helps prostate cancer patients identify and take control of their emotions.
by Kate Yandell
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
Healthy Habits
Less StressCognitive-behavioral stress management may help women with breast cancer.
by Brenda Conaway
-
Q&A
Easing Into ActivityCancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
-
Sound Advice
Spring 2016vol 06 | issue 01
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial. -
Forward Look
Weighty MattersProper nutrition plays a role in pediatric cancer care.
by Melinda Mahaffey Icden
-
Your Cancer Guide
Contemplating CAMComplementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
-
Practical Pointers
Do You Have Questions for Your Health Care Team?Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
-
Caregiving With Confidence
When Roles ChangeFollow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona